B cell antigen presentation in models of B cell a*
B 细胞 a* 模型中的 B 细胞抗原呈递
基本信息
- 批准号:7387451
- 负责人:
- 金额:$ 6.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:4-hydroxy-5-nitrophenyl acetic acidAffinityAllelesAmino AcidsAntibodiesAntibody AffinityAntigen PresentationAntigensApoptosisArchitectureAutoantibodiesAutoimmune DiseasesB cell differentiationB-Cell ActivationB-LymphocytesBone MarrowBypassCellsChronicDNADevelopmentDiseaseEnvironmental Risk FactorFollicular Dendritic CellsFrequenciesGenerationsGenesGenetically Engineered MouseHaptensHumanImmune responseImmunizationImmunoglobulin-Secreting CellsInfectionLeadLifeLupus ErythematosusMeasuresMemoryMemory B-LymphocyteModelingMusMutateMutationNitrophenolNumbersOutcomePTPRC genePathway interactionsPatientsPlasma CellsPlayPositioning AttributeProcessProductionProliferatingReactionReceptors, Antigen, B-CellRoleSerumSignal TransductionSomatic MutationSpleenStructure of germinal center of lymph nodeSystemSystemic Lupus ErythematosusSystemic TherapyT-LymphocyteTNFSF5 geneTestingTransgenesTransgenic OrganismsVirus DiseasesWeekautoreactive B cellcell typedifferentiated B cellgenetic analysisknowledge basemouse modelplasma cell differentiationpreventrecombinase
项目摘要
DESCRIPTION (provided by applicant): Systemic lupus erythematosus (SLE) is a chronic, multisystem human autoimmue disease characterized by the differentiation of short- and long-lived plasma cells (PCs) that secrete autoantibodies. Although the exact cause of SLE is unclear, environmental factors such as polyclonal B cell activation by bacterial and/or viral infection seem to play a significant role in the emergence of disease. In this case, it is anticipated that activated autoreactive B cells may participate in germinal center reaction and remain as memory cells long after infection, which may give rise to long-lived PCs secreting autoantibodies. We propose a hypothesis that memory B cells can differentiate into PCs only when receiving CD40/CD40L signals by antigen presentation to T cells. However, immunomodulatory factors such as CpG DNA may bypass this pathway, which potentially results in generation of autoreactive long-lived PC. We recently generated IA-B mice that lack MHC-II on about 95% of all B cells due to B-cell-restricted deletion of a loxP-flanked iab-neo allele by the cd19cre (Cre recombinase) transgene. Upon immunization with a T cell dependent antigen, a small number of antigen-specific MHC-II+ B cells in IA-B mice dramatically expand to differentiate into GC B cells and make normal levels of B220+ CD38+ memory B cells. However, these memory B cells lose MHC-II expression later because of ongoing deletion of MHC-II by the cd19cre transgene. In association with loss of MHC-II on memory B cells, IA-B mice showed impaired affinity maturation in long-lived PCs. With use of IAB mice, the specific aims to test our hypothesis are: 1) determination of the role of CD40/CD40L signal on memory B cell differentiation to long-lived PC by using IA-B mice carrying B cell specific CD40L transgene, and 2) determination of the effect of immunomodulatory factors that can bypass the requirement of MHC-II dependent antigen-presentation to T cells in long-lived PC differentiation. The outcome will provide a great help for understanding the development of autoreactive long-lived PCs and create new avenues for exploring therapy for SLE patients.
描述(由申请人提供):系统性红斑狼疮(SLE)是一种慢性、多系统人类自身免疫性疾病,其特征是分泌自身抗体的短寿命和长寿命浆细胞(PC)的分化。尽管 SLE 的确切病因尚不清楚,但细菌和/或病毒感染引起的多克隆 B 细胞激活等环境因素似乎在疾病的出现中发挥着重要作用。在这种情况下,预计激活的自身反应性 B 细胞可能参与生发中心反应,并在感染后很长时间内仍保留为记忆细胞,这可能会产生分泌自身抗体的长寿命 PC。我们提出一个假设,即记忆 B 细胞只有在通过抗原呈递给 T 细胞而接收 CD40/CD40L 信号时才能分化为 PC。然而,CpG DNA 等免疫调节因子可能会绕过该途径,从而可能导致自身反应性长寿命 PC 的产生。我们最近产生了约 95% 的 B 细胞缺乏 MHC-II 的 IA-B 小鼠,这是由于 cd19cre(Cre 重组酶)转基因对 loxP 侧翼的 iab-neo 等位基因的 B 细胞限制性删除。使用 T 细胞依赖性抗原进行免疫后,IA-B 小鼠中的少量抗原特异性 MHC-II+ B 细胞急剧扩增,分化为 GC B 细胞,并产生正常水平的 B220+ CD38+ 记忆 B 细胞。然而,由于 cd19cre 转基因持续删除 MHC-II,这些记忆 B 细胞后来失去了 MHC-II 表达。与记忆 B 细胞上 MHC-II 的缺失相关,IA-B 小鼠在长寿命 PC 中表现出亲和力成熟受损。使用 IAB 小鼠,检验我们的假设的具体目的是:1) 通过使用携带 B 细胞特异性 CD40L 转基因的 IA-B 小鼠,确定 CD40/CD40L 信号对记忆 B 细胞分化为长寿命 PC 的作用,以及2) 确定免疫调节因子的作用,这些因子可以绕过长寿命 PC 分化中 T 细胞 MHC-II 依赖性抗原呈递的要求。该结果将为了解自身反应性长寿命PC的发展提供很大帮助,并为探索SLE患者的治疗方法创造新途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHIKO SHIMODA其他文献
MICHIKO SHIMODA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHIKO SHIMODA', 18)}}的其他基金
B cell antigen presentation in models of B cell a*
B 细胞 a* 模型中的 B 细胞抗原呈递
- 批准号:
7192581 - 财政年份:2006
- 资助金额:
$ 6.99万 - 项目类别:
Beta cell antigen presentation in models of Beta cell a*
Beta 细胞 a* 模型中的 Beta 细胞抗原呈递
- 批准号:
7038622 - 财政年份:2006
- 资助金额:
$ 6.99万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 6.99万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 6.99万 - 项目类别:
Identification of novel therapeutic combinations for NF2 schwannomas
鉴定 NF2 神经鞘瘤的新型治疗组合
- 批准号:
10564452 - 财政年份:2023
- 资助金额:
$ 6.99万 - 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:
10579736 - 财政年份:2023
- 资助金额:
$ 6.99万 - 项目类别: